相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Romain Donne et al.
HEPATOLOGY (2023)
Hepatocellular Carcinoma Immunotherapy
Rubens Copia Sperandio et al.
ANNUAL REVIEW OF MEDICINE (2022)
Neutrophils as potential therapeutic targets in hepatocellular carcinoma
Daniel Geh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)
Emerging immunotherapy or HCC: A guide for hepatologists
Friedrich Foerster et al.
HEPATOLOGY (2022)
Clinical M2 Macrophage-Related Genes Can Serve as a Reliable Predictor of Lung Adenocarcinoma
Chaojie Xu et al.
FRONTIERS IN ONCOLOGY (2022)
Clinical Eosinophil-Associated Genes can Serve as a Reliable Predictor of Bladder Urothelial Cancer
Chaojie Xu et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
PCDH17 is regulated by methylation of DNMT3B and affects the malignant biological behavior of HCC through EMT
Yan Liu et al.
EXPERIMENTAL CELL RESEARCH (2022)
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
Benjamin Ruf et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
DNA methylation in lung cancer patients: Opening a window of life under precision medicine
Runzhang Liang et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Immune Checkpoint Inhibitors in the Treatment of HCC
Clelia Donisi et al.
FRONTIERS IN ONCOLOGY (2021)
Multimodal treatment of hepatocellular carcinoma
M. M. Kirstein et al.
INTERNIST (2020)
Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
Ann-Lii Cheng et al.
JOURNAL OF HEPATOLOGY (2020)
Prognostic role of tumor mutation burden in hepatocellular carcinoma after radical hepatectomy
Huayong Cai et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Implications of driver genes associated with a high tumor mutation burden identified using next-generation sequencing on immunotherapy in hepatocellular carcinoma
Li Li et al.
ONCOLOGY LETTERS (2020)
Tumor mutational burden is associated with poor outcomes in diffuse glioma
Lihong Wang et al.
BMC CANCER (2020)
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
Bart Vanderborght et al.
CELLS (2020)
KLF2 inhibits TGF-β-mediated cancer cell motility in hepatocellular carcinoma
Yining Li et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2020)
P-229The value of alfa-fetoprotein and neutrophil/lymphocyte ratio (NLR) in the prognosis of patients with hepatocellular carcinoma
C Quintela et al.
ANNALS OF ONCOLOGY (2019)
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial
Eileen M. O'Reilly et al.
JAMA ONCOLOGY (2019)
Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironment
Wen-Hao Xu et al.
AGING-US (2019)
From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
Yaojie Fu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
Angela Mauriello et al.
CANCERS (2019)
Correlate tumor mutation burden with immune signatures in human cancers
Xiaosheng Wang et al.
BMC IMMUNOLOGY (2019)
Implications of the tumor immune microenvironment for staging and therapeutics
Janis M. Taube et al.
MODERN PATHOLOGY (2018)
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Naoto Fujiwara et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Immunotherapy of Hepatocellular Carcinoma
Bernd Heinrich et al.
ONCOLOGY RESEARCH AND TREATMENT (2018)
Monitoring immune checkpoint regulators as Predictive Biomarkers in hepatocellular carcinoma
Ritu Shrestha et al.
FRONTIERS IN ONCOLOGY (2018)
Recurrence Patterns After Anatomic or Parenchyma-Sparing Liver Resection for Hepatocarcinoma in a Western Population of Cirrhotic Patients
Simone Famularo et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
wTO: an R package for computing weighted topological overlap and a consensus network with integrated visualization tool
Deisy Morselli Gysi et al.
BMC BIOINFORMATICS (2018)
Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
Jane Margetts et al.
BRITISH JOURNAL OF CANCER (2018)
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival
Ahmedin Jemal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
D. P. Carbone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses
Valerie Chew et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival
Ahmedin Jemal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Immunoreceptors on neutrophils
Dieke J. van Rees et al.
SEMINARS IN IMMUNOLOGY (2016)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma
Pengyuan Yang et al.
NATIONAL SCIENCE REVIEW (2014)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis
Ming Geng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma
Dong-Ming Kuang et al.
JOURNAL OF HEPATOLOGY (2011)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
Eigengene networks for studying the relationships between co-expression modules
Peter Langfelder et al.
BMC SYSTEMS BIOLOGY (2007)
Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis
George N. Ioannou et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Neutrophils and immunity: challenges and opportunities
C Nathan
NATURE REVIEWS IMMUNOLOGY (2006)